![Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role: Trends in Microbiology Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role: Trends in Microbiology](https://www.cell.com/cms/asset/3b8823a8-9335-43a4-9cbd-a5aaf3aa701b/gr1.jpg)
Therapeutic Potential of Metformin in COVID-19: Reasoning for Its Protective Role: Trends in Microbiology
![Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial | Nutrition & Diabetes Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial | Nutrition & Diabetes](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnutd.2016.37/MediaObjects/41387_2016_Article_BFnutd201637_Fig1_HTML.jpg)
Long-term treatment with metformin in obese, insulin-resistant adolescents: results of a randomized double-blinded placebo-controlled trial | Nutrition & Diabetes
![Pharmaceuticals | Free Full-Text | Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia Pharmaceuticals | Free Full-Text | Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-15-00312/article_deploy/html/images/pharmaceuticals-15-00312-ag.png?1646710544)
Pharmaceuticals | Free Full-Text | Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
![Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target? Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?](https://www.frontiersin.org/files/Articles/730048/fphys-12-730048-HTML/image_m/fphys-12-730048-g001.jpg)
Frontiers | Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?
![Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management | Cardiovascular Diabetology | Full Text Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-019-0860-y/MediaObjects/12933_2019_860_Fig1_HTML.png)